Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Who should avoid CJC-1295 Certain conditions make CJC-1295 use inadvisable: Active cancer or history of cancer, as GH and IGF-1 may promote cell proliferation
According to research, on average, people taking tirzepatide (the active ingredient in Zepbound) can lose around 20.9% of their starting body weight
This climbing rate of obesity is attributed to dietary patterns that favour high consumption of convenience foods and sweetened beverages over nutritionally sound and balanced meals
Established in 2010 with corporate headquarters in Chandigarh, the company operates state-of-the-art, ISO-certified, and WHO-GMP compliant manufacturing facilities in Baddi, Himachal Pradesh Business Type Distributor, Supplier Payment Mode Cash Advance (CA), Cash in Advance (CID), Cheque, Telegraphic Transfer (T/T), Others Related Products Explore Related Categories More Products From This Seller Compare With Similar Products Price Or Price Range 550 INR (Approx.) 1600 INR (Approx.) 1490 INR (Approx.) Minimum Order Quantity 100 Vial/Vials 1 Box/Boxes 100 Piece/Pieces Pacakaging (Quantity Per Box) SEALED NEW IN BOX 10 vials per box Drug Type Injection Injection Injection Function Other Other, Antioxidant
PMID: 26367736 [26] Dinkova-Kostova AT, Holtzclaw WD, Cole RN, et al
